Paying users zone. Data is covered by .
Get to Celgene Corp. for $17.99, or
get to entire website for at least 3 months from $49.99.
Celgene Corp. (CELG)
Enterprise Value to FCFF (EV/FCFF)
Free Cash Flow to The Firm (FCFF)
Celgene Corp., FCFF calculation
USD $ in millions
|FCFF||Free cash flow to the firm is the cash flow available to the Celgene Corp.’s suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made.||Celgene Corp.’s FCFF increased from 2016 to 2017 but then slightly declined from 2017 to 2018.|
Interest Paid, Net of Tax
Celgene Corp., interest paid, net of tax calculation
USD $ in millions
|12 months ended||Dec 31, 2018||Dec 31, 2017||Dec 31, 2016||Dec 31, 2015||Dec 31, 2014|
|Effective Income Tax Rate (EITR)|
|Interest Paid, Net of Tax|
|Interest paid, before tax|
|Less: Interest paid, tax2|
|Interest paid, net of tax|
2 Interest paid, tax = Interest paid × EITR
= × =
Enterprise Value to FCFF Ratio, Current
Celgene Corp., current EV/FCFF calculation, comparison to benchmarks
|Selected Financial Data (USD $ in millions)|
|Enterprise value (EV)|
|Free cash flow to the firm (FCFF)|
|Bristol-Myers Squibb Co.|
|Eli Lilly & Co.|
|Gilead Sciences Inc.|
|Johnson & Johnson|
|Merck & Co. Inc.|
|Regeneron Pharmaceuticals Inc.|
|Pharmaceuticals & Biotechnology|
Based on: 10-K (filing date: 2019-02-26).
If company EV/FCFF is lower then the EV/FCFF of benchmark then company is relatively undervalued.
Otherwise, if company EV/FCFF is higher then the EV/FCFF of benchmark then company is relatively overvalued.
Enterprise Value to FCFF Ratio, Historical
Celgene Corp., historical EV/FCFF calculation, comparison to benchmarks
3 EV/FCFF = EV ÷ FCFF
= ÷ =
|EV/FCFF||Enterprise value to free cash flow to the firm is whole company valuation indicator.||Celgene Corp.’s EV/FCFF ratio declined from 2016 to 2017 but then slightly increased from 2017 to 2018.|